AI Summary
We reviewed 50 live results for amgevita / yuflyma / hyrimoz (adalimumab biosimilars) and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Immunosuppressant and Monoclonal Antibody.
Comparison Table
Source: Amgevita
Description
A group of TNF inhibitor monoclonal antibody biosimilars recently approved in Singapore. These are indicated for managing conditions such as rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis.
Best for
rheumatoid arthritis patients, Crohn’s disease treatment, psoriatic arthritis care and ulcerative colitis management
Rating
Source: Amgen Inc.
Description
Amgevita is the international brand name for Amgen's adalimumab biosimilar, widely used in Canada, Europe, and New Zealand. It is indicated for the treatment of autoimmune diseases such as Hidradenitis Suppurativa, Uveitis, and juvenile idiopathic arthritis, alongside major inflammatory conditions. The product is available in convenient formats including single-use pre-filled pens and syringes.
Best for
international patients, uveitis treatment, hidradenitis suppurativa care and ankylosing spondylitis patients
Rating
Source: Sandoz
Description
Hyrimoz is an FDA-approved adalimumab biosimilar and TNF blocker used as a subcutaneous injection to treat inflammatory diseases. It is commonly prescribed for patients with rheumatoid arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, and ankylosing spondylitis. As a biologic therapy, it helps reduce inflammation and manage symptoms by targeting tumor necrosis factor (TNF) proteins in the body.
Best for
rheumatoid arthritis patients, Crohn's disease therapy, plaque psoriasis treatment, chronic inflammation management and biologic therapy users
Rating
| Compare | Amgevita / Yuflyma / Hyrimoz (Adalimumab Biosimilars) | Amgevita (adalimumab) | Hyrimoz (adalimumab-adaz) |
|---|---|---|---|
| Source | Amgevita | Amgen Inc. | Sandoz |
| Description | A group of TNF inhibitor monoclonal antibody biosimilars recently approved in Singapore. These are indicated for managing conditions such as rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis. | Amgevita is the international brand name for Amgen's adalimumab biosimilar, widely used in Canada, Europe, and New Zealand. It is indicated for the treatment of autoimmune diseases such as Hidradenitis Suppurativa, Uveitis, and juvenile idiopathic arthritis, alongside major inflammatory conditions. The product is available in convenient formats including single-use pre-filled pens and syringes. | Hyrimoz is an FDA-approved adalimumab biosimilar and TNF blocker used as a subcutaneous injection to treat inflammatory diseases. It is commonly prescribed for patients with rheumatoid arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, and ankylosing spondylitis. As a biologic therapy, it helps reduce inflammation and manage symptoms by targeting tumor necrosis factor (TNF) proteins in the body. |
| Best for | rheumatoid arthritis patients, Crohn’s disease treatment, psoriatic arthritis care and ulcerative colitis management | international patients, uveitis treatment, hidradenitis suppurativa care and ankylosing spondylitis patients | rheumatoid arthritis patients, Crohn's disease therapy, plaque psoriasis treatment, chronic inflammation management and biologic therapy users |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
AI Recommendation
If you want the most balanced option to start with, I recommend:
"Amgevita / Yuflyma / Hyrimoz (Adalimumab Biosimilars) from Amgevita."
I picked this because Offers modern biologic therapy options for several inflammatory conditions with recent HSA approval for biosimilar use.
Share this search
Related Finds